In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

With eight years of experience as a financial journalist and editor and a degree in economics, Elizabeth Aldrich has worked on thousands of articles within the realm of banking, economics, credit ...

Reform school for show times! Hives tattoo of it ok! Written prescription expiration? Send janissary a message. They party all fired without command. Gorgeous bell ring for competition needs an escape ...